Pure Global

MAGICL Insulin - India CDSCO Medical Device Registration

MAGICL Insulin is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2019/000403_d6fdcbebbc1ec12b8dc18f226bbfc0b6_ec413b33d6dd5877da75e16ec80138b7. This device is marketed under the brand name CLIA. The license holder is M/s. Reckon Diagnostics Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
MAGICL Insulin
UID: IMP/IVD/2019/000403_d6fdcbebbc1ec12b8dc18f226bbfc0b6_ec413b33d6dd5877da75e16ec80138b7

Brand Name

CLIA

Device Class

Class B

Approving Authority

CDSCO

Product Information

MAGICL Insulin (CLIA) is intended for the in vitro quantitative determination of insulin in human serum and plasma. Clinically, it is mainly used for the classification and treatment monitoring of diabetes. It also plays an important role in evaluating the activity of pancreatic islet B cells and studying insulin resistance and glucose metabolism disorders

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing